Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults aged over 18 years.

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's ...

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, ...

Bogoch says the latest vaccine was designed for a sublineage of Omicron called KP.2, which began circulating several months ...

The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

In partnership with the Bill & Melinda Gates Foundation, BioNTech is developing vaccines for HIV and tuberculosis, and its flagship covid-19 vaccine Comirnaty was co-developed with Pfizer.

The activist investor claims Pfizer failed to capitalize on the windfall earned from its COVID-19 vaccine and, in the process ...

With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

Experiments with mice that received repeated mRNA vaccination showed evidence of neutralizing antibody–producing cells in the ...

A year after the first samRNA vaccine approval, experts say others are likely to face scientific and regulatory hurdles.